Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
American Journal of Public Health|May 1, 1990
Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccineM T Pasko, T R BeamAntimicrobial Agents and Chemotherapy|May 1, 1987
Serum bactericidal rate as measure of antibiotic interactionsL L Briceland, M T Pasko, J M MylotteAntimicrobial Agents and Chemotherapy|September 1, 1989
Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curveJ E Tisdale, M T Pasko, J M MylotteJournal of Pharmaceutical Sciences|October 1, 1989
Factors affecting ceftriaxone plasma protein binding during open heart surgeryG L Jungbluth, M T Pasko, W J JuskoDICP : the Annals of Pharmacotherapy|September 1, 1990
Fluconazole: a new triazole antifungal agentM T Pasko, S C Piscitelli, A D Van SlootenAntimicrobial Agents and Chemotherapy|June 1, 1989
Ceftriaxone disposition in open-heart surgery patientsG L Jungbluth, M T Pasko, T R Beam, et al.The Journal of Antimicrobial Chemotherapy|March 1, 1985
Safety and pharmacokinetics of ceftazidime in patients with chronic hepatic dysfunctionM T Pasko, T R Beam, J A Spooner, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1988
Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patientsM T Pasko, W R Bartholomew, T R Beam, et al.The Annals of Pharmacotherapy|February 1, 1994
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazoleT H Grasela, S D Goodwin, M T Pasko, et al.Pharmacotherapy|January 1, 1990
Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypassA N Kong, G L Jungbluth, M T Pasko, et al.Pageof 2